Pharmaceutical major Nicholas Piramal India is planning to phase out its tertiary brands which accounted for 9 per cent of its revenue during 2001-02.
Top Section
Explore Business Standard
Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Pharmaceutical major Nicholas Piramal India is planning to phase out its tertiary brands which accounted for 9 per cent of its revenue during 2001-02.
First Published: Jun 11 2002 | 12:00 AM IST